Changes in ADMA/DDAH Pathway after Hepatic Ischemia/Reperfusion Injury in Rats: The Role of Bile

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Ferrigno, Andrea ^a   Rizzo, Vittoria ^b   Bianchi, Alberto ^a   Di Pasqua, Laura G ^a   Berardo, Clarissa ^a   Richelmi, Plinio ^a   Vairetti, Mariapia ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; BILIRUBIN GLUCURONIDE; DIMETHYLARGININASE; DIMETHYLARGININASE 1; GLUTATHIONE; GLUTATHIONE DISULFIDE; MESSENGER RNA; N(G),N(G) DIMETHYLARGININE; PEPTIDES AND PROTEINS; PROTEIN METHYLTRANSFERASE; PROTEIN METHYLTRANSFERASE 1; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; AMIDASE; ARGININE; N,N-DIMETHYLARGININE; PRMT1 PROTEIN, RAT; PROTEIN ARGININE METHYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE; BILE DUCT LIGATION; BILIARY EXCRETION; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; INTRACELLULAR SPACE; LIPID PEROXIDATION; LIVER BIOPSY; LIVER INJURY; LIVER ISCHEMIA; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; ANALOGS AND DERIVATIVES; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; DISEASE MODEL; GENETICS; INJURIES; LIVER; METABOLISM; PHYSIOLOGY; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

AMIDOHYDROLASES; ANIMALS; ARGININE; BILE; CATIONIC AMINO ACID TRANSPORTER 2; DISEASE MODELS, ANIMAL; LIVER; MALE; ORGAN SPECIFICITY; OXIDATIVE STRESS; PROTEIN-ARGININE N-METHYLTRANSFERASES; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 84929010485     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/627434     Document Type: Article

References (47)

1. U. Forstermann, H. H. Schmidt, J. S. Pollock, et al., "Isof orms of nitric oxide synthase. Characterization and purification from different cell types, " Biochemical Pharmacology, vol. 42, no. 10, pp. 1849-1857, 1991.
2. M. C. Richir, R. H. Bouwman, T. Teerlink, M. P. C. Siroen, T. P. G. M. de Vries, and P. A. M. van Leeuwen, "The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function, " Journal of Parenteral and Enteral Nutrition, vol. 32, no. 6, pp. 613-621, 2008.
3. D. Zakrzewicz and O. Eickelberg, "From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases, " BMC PulmonaryMedicine, vol. 9, article 5, 2009.
4. C. Zoccali, "Asymmetric dimethylarginine in end-stage renal disease patients: a biomarker modifiable by calcium blockade and angiotensin II antagonism?" Kidney International, vol. 70, no. 12, pp. 2053-2055, 2006.
5. M. Kimoto, G. S. Whitley, H. Tsuji, and T. Ogawa, "Detection of NG, NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody, " The Journal of Biochemistry, vol. 117, no. 2, pp. 237-238, 1995.
6. M. Kimoto, H. Tsuji, T. Ogawa, and K. Sasaoka, "Detection of NG, NG -dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody, " Archives of Biochemistry and Biophysics, vol. 300, no. 2, pp. 657-662, 1993.
7. R. J. Nijveldt, T. Teerlink, M. P. C. Siroen, A. A. Van Lambalgen, J. A. Rauwerda, and P. A. M. Van Leeuwen, "The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA), " Clinical Nutrition, vol. 22, no. 1, pp. 17-22, 2003.
8. F. Palm, M. L. Onozato, Z. Luo, and C. S. Wilcox, "Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 293, no. 6, pp. H3227-H3245, 2007.
9. Y. Hattori, K. Kasai, and S. S. Gross, "Cationic amino acid transporter gene expression inculturedvascular smoothmuscle cells and in rats, " The American Journal of Physiology-Heart and Circulatory Physiology, vol. 276, no. 6, pp. H2020-H2028, 1999.
10. J. P. Cooke, "Asymmetrical dimethylarginine: the ubermarker?" Circulation, vol. 109, no. 15, pp. 1813-1819, 2004.
11. H. He, S. Wang, X. Li, et al., "Anovelmetabolic balancemodel for describing themetabolic disruption of and interactions between cardiovascular-related markers during acutemyocardial infarction, " Metabolism: Clinical and Experimental, vol. 62, no. 10, pp. 1357-1366, 2013.
12. J. T. Kielstein and C. Zoccali, "Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?" The American Journal of Kidney Diseases, vol. 46, no. 2, pp. 186-202, 2005.
13. R. P. Mookerjee, R. N. Dalton, N. A. Davies, et al., "Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure, " Liver Transplantation, vol. 13, no. 3, pp. 400-405, 2007.
14. P. Vallance, A. Leone, A. Calver, J. Collier, and S. Moncada, "Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure, " The Lancet, vol. 339, no. 8793, pp. 572-575, 1992.
15. A. Surdacki, "L-arginine analogs-inactive markers or active agents in atherogenesis?" Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 6, no. 4, pp. 302-311, 2008.
16. R. Schnabel, S. Blankenberg, E. Lubos, et al., "Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study, " Circulation Research, vol. 97, no. 5, pp. e53-e59, 2005.
17. M. Trocha, A. Merwid-Lad, E. Chlebda-Sieragowska, et al., "Age-related changes in adma-ddah-no pathway in rat liver subjected to partial ischemia followed by global reperfusion, " Experimental Gerontology, vol. 50, pp. 45-51, 2014.
18. G. P. Yagnik, Y. Takahashi, G. Tsoulfas, K. Reid, N. Murase, and D. A. Geller, "Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury, " Hepatology, vol. 36, no. 3, pp. 573-581, 2002.
19. P. Martin-Sanz, L. Olmedilla, E. Dulin, et al., "Presence of methylated arginine derivatives in orthotopic human liver transplantation: relevance for liver function, " Liver Transplantation, vol. 9, no. 1, pp. 40-48, 2003.
20. W. Laleman, A. Omasta, M. van de Casteele, et al., "A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis, " Hepatology, vol. 42, no. 6, pp. 1382-1390, 2005.
21. G. Palladini, A. Ferrigno, V. Rizzo, et al., "Lobe-specific heterogeneity and matrix metalloproteinase activation after ischemia/reperfusion injury in rat livers, " Toxicologic Pathology, vol. 40, no. 5, pp. 722-730, 2012.
22. V. Rizzo, A. Anesi, L. Montalbetti, G. Bellantoni, R. Trotti, and G. V. MelziDEril, "Reference values of neuroactive amino acids in the cerebrospinal fluid by high-performance liquid chromatography with electrochemical and fluorescence detection, " Journal of Chromatography A, vol. 729, no. 1-2, pp. 181-188, 1996.
23. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Rand all, "Protein measurement with the Folin phenol reagent, " The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265-275, 1951.
24. Y. Tain and C. Baylis, "Determination of dimethylarginine dimethylaminohydrolase activity in the kidney, " Kidney International, vol. 72, no. 7, pp. 886-889, 2007.
25. P. Chomczynski and K. Mackey, "Substitution of chlorof orm by bromo-chloropropane in the single-step method of RNA isolation, " Analytical Biochemistry, vol. 225, no. 1, pp. 163-164, 1995.
26. H. Esterbauer and K. H. Cheeseman, "Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal, "Methods in Enzymology, vol. 186, pp. 407-421, 1990.
27. M. Trocha, A. Merwid-Lad, A. Szuba, et al., "Effect of simvastatin on nitric oxide synthases (eNOS, iNOS) and arginine and its derivatives (ADMA, SDMA) in ischemia/reperfusion injury in rat liver, " Pharmacological Reports, vol. 62, no. 2, pp. 343-351, 2010.
28. P. Lluch, B. Torondel, P. Medina, et al., "Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis, " Journal of Hepatology, vol. 41, no. 1, pp. 55-59, 2004.
29. R. P. Mookerjee, M. Malaki, N. A. Davies, et al., "Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis, " Hepatology, vol. 45, no. 1, pp. 62-71, 2007.
30. A. Cziraki, Z. Ajtay, A. Nemeth, et al., "Effects of coronary revascularization with or without cardiopulmonary bypass on plasma levels of asymmetric dimethylarginine, " Coronary Artery Disease, vol. 22, no. 4, pp. 245-252, 2011.
31. M. P. C. Siroen, M. C. Warle, T. Teerlink, et al., "The transplanted liver graft is capable of clearing asymmetric dimethylarginine, " Liver Transplantation, vol. 10, no. 12, pp. 1524-1530, 2004.
32. T. Brenner, T. H. Fleming, C. Rosenhagen, et al., "L-arginine and asymmetric dimethylarginine are early predictors for survival in septic patients with acute liver failure, " Mediators of Inflammation, vol. 2012, Article ID 210454, 11 pages, 2012.
33. Y. Tain, Y. Kao, C. Hsieh, et al., "Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine, " Free Radical Biology and Medicine, vol. 49, no. 6, pp. 1088-1098, 2010.
34. M. Fukai, T. Hayashi, R. Yokota, et al., "Lipid peroxidation during ischemia depends on ischemia time in warm ischemia and reperfusion of rat liver, " Free Radical Biology and Medicine, vol. 38, no. 10, pp. 1372-1381, 2005.
35. X. Hu, D. Atzler, X. Xu, et al., "Dimethylarginine dimethylaminohydrolase is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 7, pp. 1540-1546, 2011.
36. D. Wang, P. S. Gill, T. Chabrashvili, et al., "Isof orm-specific regulation by NG, NG-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO, " Circulation Research, vol. 101, no. 6, pp. 627-635, 2007.
37. K. Hasegawa, S. Wakino, S. Tatematsu, et al., "Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2, " Circulation Research, vol. 101, pp. e2-e10, 2007.
38. M. Davids, M. C. Richir, M. Visser, et al., "Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness, " Metabolism: Clinical and Experimental, vol. 61, no. 4, pp. 482-490, 2012.
39. R. Lanteri, R. Acquaviva, C. DiGiacomo, et al., "Rutin in rat liver ischemia/reperfusion injury: effect on DDAH/NOS pathway, " Microsurgery, vol. 27, no. 4, pp. 245-251, 2007.
40. G. L. Volti, V. Sorrenti, R. Acquaviva, et al., "Effect of ischemiareperfusion on renal expression and activity of NG-NGDimethylarginine dimethylaminohydrolases, " Anesthesiology, vol. 109, no. 6, pp. 1054-1062, 2008.
41. T. Hu, M. Chouinard, A. L. Cox, et al., "Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation, " Journal of Biological Chemistry, vol. 281, no. 52, pp. 39831-39838, 2006.
42. T. Fujino, K. Murakami, I. Ozawa, et al., "Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway, " FEBS Journal, vol. 276, no. 5, pp. 1319-1332, 2009.
43. Z. Wang, Y. Liu, Y. Han, et al., "Protective effects of aliskiren on ischemia-reperfusion-induced renal injury in rats, " European Journal of Pharmacology, vol. 718, pp. 160-166, 2013.
44. M. Trocha, A. Merwid-Lad, T. Sozanski, et al., "Influence of ezetimibe on ADMA-DDAH-NOpathway in rat liver subjected to partial ischemia followed by global reperfusion, " Pharmacological Reports, vol. 65, no. 1, pp. 122-133, 2013.
45. T. Teerlink, Z. Luo, F. Palm, and C. S. Wilcox, "Cellular ADMA: regulation and action, " Pharmacological Research, vol. 60, no. 6, pp. 448-460, 2009.
46. B. Betz, K. Moller-Ehrlich, T. Kress, et al., "Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency, " Translational Research, vol. 162, no. 2, pp. 67-76, 2013.
47. T. A. Koeppel, J. C. Thies, P. Schemmer, et al., "Inhibition of nitric oxide synthesis in ischemia/reperfusion of the rat liver is followed by impairment of hepatic microvascular blood flow, " Journal of Hepatology, vol. 27, no. 1, pp. 163-169, 1997.